InVision AG

  • WKN: 585969
  • ISIN: DE0005859698
  • Land: Deutschland

Nachricht vom 07.05.2020 | 08:37

InVision AG: Consolidated Interim Statements of First Quarter of 2020 Fiscal Year

DGAP-News: InVision AG / Key word(s): Quarterly / Interim Statement/Quarter Results
07.05.2020 / 08:37
The issuer is solely responsible for the content of this announcement.

InVision AG: Consolidated Interim Statements of First Quarter of 2020 Fiscal Year

Düsseldorf (Germany), 7 May 2020 - 
Within the first three months of 2020 fiscal year, InVision AG (ISIN: DE0005859698) generated total revenues of EUR 3.114 million. Compared to the first quarter of 2019, this corresponds to a decrease of 4 percent (3M 2019: EUR 3.228 million). Revenues in the product range of Workforce Management decreased by 4 percent down to EUR 2.998 million (3M 2019: EUR 3.123 million). In the Education segment, revenues increased by 10 percent up to EUR 0.116 million (3M 2019: EUR 0.105 million).

In the first quarter of 2020, the Company recorded a 29 percent improvement in EBIT (Earnings Before Interest and Taxes), totaling EUR 0.239 million (3M 2019: EUR 0.185 million). The EBIT margin was at 8 percent (3M 2019: 6 percent). The consolidated result decreased by 67 percent to EUR 0.033 million (3M 2019: EUR 0.101 million). This decrease is mainly due to the proportionate reduction of deferred tax assets from the internal license transfer in 2019. Accordingly, earnings per share also declined to EUR 0.01 (3M 2019: EUR 0.05).

The operating cash flow decreased by 40 percent to EUR 1.747 million (3M 2019: EUR 2.923 million). Liquid funds rose to EUR 9.290 million as of 31 March 2020 (31 December 2019: EUR 2.616 million). This increase is largely attributable to the call in of the remaining EUR 5 million of the bank loan that was raised in 2019, in order to secure liquidity. 

At present, the Company cannot assess the medium to longer-term effects of the Corona pandemic on the economic activities of its customers and on the economy as a whole, but it does monitor developments in this regard on a daily basis.

The Company's Consolidated Interim Statements for the first three months of the 2020 financial year is now available on the Company's website at: www.ivx.com/en/investors/financial-reports.  

About InVision:
Since 1995, InVision has been helping its clients to increase their productivity and quality of work and reduce their costs. The InVision group incorporates the brands injixo, a cloud-based workforce management solution for contact centres, The Call Center School, offering cloud-learning courses for contact centre professionals, and InVision WFM, a software solution for workforce management. InVision AG (IVX) is listed in the Prime Standard Segment of the Frankfurt Stock Exchange.
Further information: www.ivx.com

Contact:
InVision AG
Investor Relations,
Jutta Handlanger
Speditionstraße 5,
40221 Düsseldorf (Germany),
phone: +49 (0)211 781-781-66,
email: ir@invision.de



07.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Anleihe der German Real Estate Capital S.A. stark überdurchschnittlich attraktiv

Die Anleihe der German Real Estate Capital S.A. weist aktuell eine Effektivverzinsung von ca. 14 % auf. Da es sich hier quasi um eine Immobilien-Anleihe handelt, ist das Anleiherisiko überschaubar. Insgesamt verfügt die German Real Estate-Gruppe über 6 Objekte, 24 Bestands- und 22 Handelsobjekte, womit eine Kombination aus stetigen Einnahmen und attraktiven Entwicklerrenditen erreicht wird. Wir stufen die Anleihe als stark überdurchschnittlich attraktiv ein.

News im Fokus

Linde plc: Linde Announces Pricing of $1 Billion Notes

04. August 2020, 12:00

Aktueller Webcast

TRATON SE

Pressekonferenz – Halbjahresfinanzbericht 2020 – Webcast

31. Juli 2020

Aktuelle Research-Studie

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Kaufen Pharming Group NV

04. August 2020